Skip to content

Frontiers in Psychiatry

ISSN 1664-0640

601 papers in the library · 9,228 citations · publishing 2010-2026

Papers

Sort Most recent Most cited

From analytic to synthetic-organizational pluralisms: A pluralistic enactive psychiatry.

Frontiers in Psychiatry 2022 Christophe Gauld, Kristopher Nielsen, Manon Job et al. 13 citations

Reliance on sole reductionism, whether explanatory, methodological or ontological, is difficult to support in clinical psychiatry. Rather, psychiatry is challenged by a plurality of approaches. There exist multiple legitimate ways of understanding human functionality and disorder, i.e., different systems of representation, different tools, different methodologies and objectives. Pluralistic...

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management.

Frontiers in Psychiatry 2022 Ryan Yip, Jennifer Swainson, Atul Khullar et al. 13 citations

Ketamine is a versatile medication with an emerging role for the treatment of numerous psychiatric conditions, including treatment resistant depression. Current psychiatry guidelines for its intravenous administration to treat depression recommend regular blood pressure monitoring and an aggressive approach to potential transient hypertensive episodes induced by ketamine infusions. While this...

DOI: 10.3389/fpsyt.2022.1017504 (opens in new tab) Full text (opens in new tab) Hypertension Hypertensive emergency Ketamine infusion Treatment resistant depression

Preliminary evidence of links between ayahuasca use and the corpus callosum.

Frontiers in Psychiatry 2022 Otto Simonsson, José Carlos Bouso, Florian Kurth et al. 6 citations

Recent research suggests that ayahuasca and its alkaloid-containing ingredients may be helpful in the treatment and prevention of certain movement and neurodegenerative disorders. However, such research is still in its infancy and more studies in normative samples seem necessary to explore effects of ayahuasca on clinically relevant brain structures, such as the corpus callosum. The purpose of...

Psychotic-like experiences among university female students in Qatar: A qualitative-phenomenological study.

Frontiers in Psychiatry 2022 Arij Yehya, Salma M Khaled, Iris E C Sommer et al. 4 citations

Psychotic-like experiences (PLEs) are hallucinatory or delusional experiences that fall below the threshold of a diagnosable psychotic disorder. Although PLEs are common across the spectrum of psychiatric disorders, they also have been commonly reported in the general population. In this study, we aimed to describe the types of PLEs experienced by university students in Qatar. Furthermore, we...

DOI: 10.3389/fpsyt.2022.988913 (opens in new tab) Full text (opens in new tab) Middle east Culture Non-clinical sample Psychotic-like experiences +2

Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.

Frontiers in Psychiatry 2022 Udo Bonnet, Michael Specka, Ann-Kristin Kanti et al. 4 citations

There is a lack of benefit/harm assessments of illicit and licit psychoactive substances performed by substance-dependent users in comparison to addiction medicine experts. We extended the analyses of substance harm/benefit assessments of German addiction medicine experts (N = 101), in parts reported recently in this journal [doi.org/10.3389/fpsyt.2020.59219], by the perspectives of...

Disembodied Language in Early-Onset Schizophrenia.

Frontiers in Psychiatry 2022 Przemysław Zakowicz, Maria Skibińska, Joanna Pawlak 3 citations

A recent view on schizophrenia phenomenology underlines the impaired relations between the mind and the body. An aberrant feeling of ipseity may be the real source of suffering of the patients from psychosis and impacts general symptomatology. The disturbed connection between thinking processes and environmental stimuli may lead to language disembodiment. In the study, we aimed to...

Consciousness alterations in a cohort of young Swiss men: Associations with substance use and personality traits.

Frontiers in Psychiatry 2022 Marianthi Lousiana Deligianni, Joseph Studer, Gerhard Gmel et al. 1 citation

Substance-induced consciousness alterations (CA) have mainly been studied among users of psychedelics but not among people using street drugs. Explore occurrences of three different types of substance-induced CA [ego dissolution (ED), visual pseudo-hallucinations (VPH), anxiety/paranoia (A/P)] and their perceived influences on life, together with their associations with substance use and...

DOI: 10.3389/fpsyt.2022.1056159 (opens in new tab) Full text (opens in new tab) Personality Psychedelics Substance use Young men

Mindfulness-Based Cognitive Therapy Regulates Brain Connectivity in Patients With Late-Life Depression.

Frontiers in Psychiatry 2022 Hui Li, Wei Yan, Qianwen Wang et al.

Late-life depression (LLD) is an important public health problem among the aging population. Recent studies found that mindfulness-based cognitive therapy (MBCT) can effectively alleviate depressive symptoms in major depressive disorder. The present study explored the clinical effect and potential neuroimaging mechanism of MBCT in the treatment of LLD. We enrolled 60 participants with LLD in an...

DOI: 10.3389/fpsyt.2022.841461 (opens in new tab) Full text (opens in new tab) Amygdala Functional connection Late-life depression Magnetic resonance imaging +2

Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder.

Frontiers in Psychiatry 2022 Joshua Willms, Ben McCauley, Lindsay Kerr et al.

Suicide is the most common cause of death in male resident physicians and the second most common cause of death in resident physicians overall. Physicians also experience high rates of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and burnout. These conditions frequently develop during medical school, and threaten not only physicians but the patients they care for. A...

DOI: 10.3389/fpsyt.2022.1020214 (opens in new tab) Full text (opens in new tab) Depression Ketamine assisted psychotherapy Medical school Suicidality

Corrigendum: A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression.

Frontiers in Psychiatry 2022 Shannon Dames, Pamela Kryskow, Crosbie Watler correction

Corrigendum: A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers with PTSD and DepressionError in Figure/TableIn the published article, there was an error in Figure 2 as published. The PTSD label on the legend that is imbedded in the figure was on the legend component of the figure was posted on the anxiety...

Mindfulness Training Intervention With the Persian Version of the Mindfulness Training Mobile App for Premenstrual Syndrome: A Randomized Controlled Trial.

Frontiers in Psychiatry 2022 Dorsa Mazaheri Asadi, Komeil Zahedi Tajrishi, Banafsheh Gharaei

Premenstrual syndrome (PMS) is a common problem for women of reproductive age, affecting various aspects of their lives. While various in-person psychotherapeutic interventions, including Mindfulness therapy, have yielded promising results in reducing PMS symptoms, due to the COVID-19 Pandemic, psychotherapists are providing their services via online methods. Therefore, the present study is the...

DOI: 10.3389/fpsyt.2022.922360 (opens in new tab) Full text (opens in new tab) Mindfulness-app Mobile health mhealth Premenstrual syndrome Quality of life

The incubus phenomenon: Prevalence, frequency and risk factors in psychiatric inpatients and university undergraduates.

Frontiers in Psychiatry 2022 Marc L. Molendijk, Ouarda Bouachmir, Harriët Montagne et al.

The incubus phenomenon is a paroxysmal sleep-related disorder characterized by the visuotactile sensation of a person or entity exerting pressure on one's thorax during episodes of sleep paralysis and (apparent) wakefulness. This terrifying phenomenon is relatively unknown even though a previous meta-analysis indicated a lifetime prevalence of 0.11 for individuals in the general population and...

DOI: 10.3389/fpsyt.2022.1040769 (opens in new tab) Full text (opens in new tab) Autoscopy Entity experience False awakening Parasomnia +4

Paving the way for systemic phenomenological psychiatry - the forgotten heritage of Wolfgang Blankenburg.

Frontiers in Psychiatry 2022 Samuel Thoma, Michael Konrad, Lisa C. Fellin et al.

Phenomenological psychopathology focuses on the first-person experience of mental disorders. Although it is in principle descriptive, it also entails an explanatory dimension: single psychological symptoms are conceived as genetically arising from a holistic structure of personal experience, i.e., the patient's being-in-the-world - and of its dynamic unfolding over time. Yet both classical and...

DOI: 10.3389/fpsyt.2022.909488 (opens in new tab) Full text (opens in new tab) Phenomenological psychopathology Phenomenological sociology Systemic therapy Therapy of psychosis

What is better for psychiatry: Titrated or fixed concentrations of nitrous oxide?

Frontiers in Psychiatry 2022 Mark A Gillman

Medication dosages are crucial-no single dose fits all. My paper compares the safety, scientific and practical applicability of fixed 25-50% concentrations of nitrous oxide (N2O) with the variable titrated concentrations of Psychotropic Analgesic N2O (PAN), as used in dentistry, and neuropsychiatry. A crucial difference is that PAN is always titrated, via an open circuit (nasal mask), to the...

Mindfulness-Based Cognitive Therapy in Recurrent MDD Patients With Residual Symptoms: Alterations in Resting-State Theta Oscillation Dynamics Associated With Changes in Depression and Rumination.

Frontiers in Psychiatry 2022 Jing Wang, Feng Ren, Bingling Gao et al.

Many patients with major depressive disorder (MDD) suffer from residual symptoms. Rumination is a specific known risk factor for the onset, severity, prolongation, and relapse of MDD. This study aimed to examine the efficacy and EEG substrates of mindfulness-based cognitive therapy (MBCT) in alleviating depression and rumination in an MDD population with residual symptoms. We recruited 26...

DOI: 10.3389/fpsyt.2022.818298 (opens in new tab) Full text (opens in new tab) Electroencephalography Major depressive disorders Mindfulness-based cognitive therapy Residual symptoms +2

Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence.

Frontiers in Psychiatry 2022 Sarah Beggiato, Alessandro Ieraci, Mariachiara Zuccarini et al.

Cannabis abuse during adolescence is a risk factor for cognitive impairments in psychiatric disorders later in life. To date, the possible causal relationship between cannabinoids, kynurenic acid (KYNA; i.e., a neuroactive metabolite of tryptophan degradation) and cognition has not been investigated in adolescence. Early exposure to delta 9-tetrahydrocannabinol (THC; i.e., the main psychotropic...

Mindfulness-Based Stress Reduction in Pre-symptomatic Genetic Frontotemporal Dementia: A Pilot Study.

Frontiers in Psychiatry 2022 Jackie M Poos, Esther Van den Berg, Janne M Papma et al.

Pre-symptomatic frontotemporal dementia (FTD) mutation carriers and first-degree family members that are 50% at-risk for FTD may experience symptoms of anxiety and depression as a result of the ambiguity of when or if symptoms of the disease will manifest. We conducted a pilot study to investigate the use of an online mindfulness-based stress reduction (MBSR) course to reduce symptoms of...

Erratum: A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development

Frontiers in Psychiatry December 24, 2021 Frontiers Production Office correction

Due to a production error, the word 'story' was misspelled in the article. A correction has been made to all instances of 'storey' and 'storeys' in the article. They have been corrected to 'story' and 'stories'.Due to a production error, reference citation (1) was incorrectly linked in the Introduction, line 3 and line 5. The citation on line 3 has now been linked to the corresponding...

DOI: 10.3389/fpsyt.2021.832766 (opens in new tab) Full text (opens in new tab) Psilocybin-assisted psychotherapy Psychological flexibility Self-perspective taking Psychedelic +1

Substance-Induced Psychoses: An Updated Literature Review

Frontiers in Psychiatry December 23, 2021 A. Fiorentini, Filippo Cantù, Camilla Crisanti et al. 123 citations

Background: On the current psychopharmacological panorama, the variety of substances able to provoke an episode of acute psychosis is rapidly increasing. Such psychotic episodes are classified according to the major category of symptoms: positive, negative, or cognitive psychotic episodes. On one hand, the abuse of methamphetamines, cannabis, and cocaine plays a big role in increasing the...

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Frontiers in Psychiatry December 17, 2021 John R. Kelly, Claire M. Gillan, Jack Prenderville et al. 66 citations

Accumulating clinical evidence shows that psychedelic therapy, by synergistically combining psychopharmacology and psychological support, offers a promising transdiagnostic treatment strategy for a range of disorders with restricted and/or maladaptive habitual patterns of emotion, cognition and behavior, notably, depression (MDD), treatment resistant depression (TRD) and addiction disorders,...

DOI: 10.3389/fpsyt.2021.800072 (opens in new tab) Anxiety Research domain criteria Psychotherapist Cognition +2

A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development

Frontiers in Psychiatry December 7, 2021 Henry J. Whitfield 27 citations

Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major depressive disorder). The psychotherapeutic treatments accompanying these psychedelics have not been well-studied and remain controversial. This...

DOI: 10.3389/fpsyt.2021.727572 (opens in new tab) Psilocybin Psychological intervention Psychotherapist Context archaeology +4

Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population

Frontiers in Psychiatry December 3, 2021 Anum Muzaffar, Sami Ullah, Fazal Subhan et al. 12 citations

Cannabis abuse is a common public health issue and may lead to considerable adverse effects. Along with other effects, the dependence on cannabis consumption is a serious problem which has significant consequences on biochemical and clinical symptoms. This study intends to evaluate the harmful effects of the use of cannabis on thyroid hormonal levels, cardiovascular indicators, and psychotic...

DOI: 10.3389/fpsyt.2021.730388 (opens in new tab) Psychopathology Schizoaffective disorder Schizophrenia object-oriented programming Psychosis +5

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases

Frontiers in Psychiatry December 2, 2021 Maria Gałuszko‐węgielnik, Adam Włodarczyk, Wiesław Jerzy Cubała et al. 5 citations

Purpose: Approximately 30% of patients with major depressive disorder (MDD) are treatment resistant. There is an unquestionable need for new treatment strategies. Subanesthetic doses of intravenous (IV) ketamine have a rapid antidepressant effect in treatment-resistant depression (TRD). This paper describes the efficacy of repeated series of intravenous ketamine infusions as an add-on treatment...

The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy

Frontiers in Psychiatry November 26, 2021 Ahmad Rehman, Habib Syed, Kathryn Forcer et al. 40 citations

Introduction: Psychedelic-assisted psychotherapy is a promising approach in psychiatry; evidence is growing and it may not be long before mainstream services are expected to offer it to selected patients. This pilot study examined the attitudes and knowledge of NHS psychiatrists of all levels towards psychedelic-assisted psychotherapy and explored potential barriers and facilitators to its...

DOI: 10.3389/fpsyt.2021.743599 (opens in new tab) Thematic analysis Focus group Mainstream Mental health +3

An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression.

Frontiers in Psychiatry November 24, 2021 Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch et al. 47 citations

Research over the last two decades has established ketamine as a safe, effective, fast-acting, and sustained antidepressant that significantly reduces adverse symptoms associated with depression, even in patients who are treatment resistant. Much of this research has evolved within the framework of several independent branches of scientific inquiry: in addition to the study of ketamine is a...

DOI: 10.3389/fpsyt.2021.710338 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Therapeutic outcomes Ketamine therapy ketamine Psychotherapy supportive treatments +2